Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1 1

Status

Recruiting 3Completed 2Active not recruiting 2Terminated 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 8Gastrointestinal 4Genitourinary 2Breast 2Thoracic 1Head & Neck 1Endocrine 1

Conditions

Urologic Neoplasms 1Prostatic Neoplasms 1Neoplasm Metastasis 1Carcinoma, Transitional Cell 1

Interventions

Docetaxel 205Prednisone 151enzalutamide 128Gemcitabine 122Radiotherapy 116Sunitinib 112Cisplatin 102Leuprolide 98pembrolizumab 95Abiraterone Acetate 94bicalutamide 87Nivolumab 85Goserelin 83Sorafenib 80Paclitaxel 79Carboplatin 77Everolimus 72Bevacizumab 71Magnetic Resonance Spectroscopy 65acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 61pazopanib 56radium Ra 223 dichloride 50Ipilimumab 49Zoledronic Acid 47Radiosurgery 43Cyclophosphamide 43Filgrastim 42abiraterone 41gallium 68 PSMA-11 40Surveys and Questionnaires 40

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Lymph Node Excision × Genitourinary × Clear all
NCT02036918 2020-03-31

Dendreon Lymph Node Biopsy in Metastatic Castrate-Resistant Prostate Cancer

Duke University

Phase 1 Completed
20 enrolled
Genitourinary

Neoplasm Metastasis, Prostatic Neoplasms

NCT00751140 2017-05-30

Merits of Performing a Modified Template Retroperitoneal Lymph Node Dissection

H. Lee Moffitt Cancer Center and Research Institute

Phase NA Completed
20 enrolled 7 charts
Genitourinary

Carcinoma, Transitional Cell, Urologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡